Barbara Lugato, PhD

Barbara Lugato, PhD, is a postdoc at the LBI:AD. Her main interest is the development of new radiopharmaceuticals for cancer imaging and therapy.

She has a background in organic chemistry and radiochemistry. She obtained her PhD in Milan, Italy (Università Milano-Bicocca) where she focused on F-18 radiolabeling of biomolecules. She joined the group of Prof. Stephen Hanessian (Université de Montréal, Canada) where she dedicated to the organic chemistry synthesis of DNA mimics for antisense therapy. She is currently working for Orano, a multinational nuclear company supporting the LBI:AD. 

Barbara Lugato